Leaky gut and autoimmune diseases

Clinical Reviews in Allergy and Immunology

Volumn 42, Issue 1, 2012, Pages 71-78

  Fasano, Alessio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antigens; Autoimmunity; Gut permeability; Immune response; Tight junctions; Zonulin

Indexed keywords

GAMMA INTERFERON; GLUTEN; PLASMA PROTEIN; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSING SPONDYLITIS; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; CELIAC DISEASE; ENTERITIS; GASTROINTESTINAL TRACT; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NEUROENDOCRINE DISEASE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; CHOLERA TOXIN; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL MUCOSA;

EID: 84857052969     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-011-8291-x     Document Type: Article

References (55)

1. A Perl 2004 Pathogenesis and spectrum of autoimmunity Methods Mol Med 102 1 8 15286377 1:CAS:528:DC%2BD2cXotFahsL4%3D
2. U Christen MG von Herrath 2004 Induction, acceleration or prevention of autoimmunity by molecular mimicry Mol Immunol 40 1113 1120 15036917 10.1016/j.molimm.2003.11.014 1:CAS:528:DC%2BD2cXht1ansrY%3D (Pubitemid 38221193)
3. Fasano A (2001) Pathological and therapeutic implications of macromolecule passage through the tight junction. In Tight Junctions. CRC Press, Inc, Boca Raton, pp 697-722
4. QH Yu Q Yang 2009 Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier Cell Biol Int 33 78 82 18938254 10.1016/j.cellbi.2008.09.007
5. A Fasano 2001 Intestinal zonulin: open sesame! Gut 49 159 162 11454785 10.1136/gut.49.2.159 1:STN:280:DC%2BD3Mvgtlejtw%3D%3D (Pubitemid 32675102)
6. A Fasano T Shea-Donohue 2005 Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases Nat Clin Pract Gastroneterol Hepatol 2 416 422 10.1038/ncpgasthep0259 1:CAS:528:DC%2BD2MXhtVyhtr3O (Pubitemid 41486094)
7. RM Plenge 2010 Unlocking the pathogenesis of celiac disease Nat Genet 42 281 282 20348961 10.1038/ng0410-281 1:CAS:528:DC%2BC3cXjvFarsbw%3D
8. S Drago R El Asmar M De Pierro, et al. 2006 Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines Scand J Gastroenterol 41 408 419 16635908 10.1080/00365520500235334 1:CAS:528:DC%2BD28XjvVaktb4%3D (Pubitemid 43675406)
9. JL Madara JS Trier 1980 Structural abnormalities of jejunal epithelial cell membranes in celiac sprue Lab Inves 43 254 261 1:STN:280: DyaL3c3lt1OmtA%3D%3D (Pubitemid 10061705)
10. DN Szakál H Gyorffy A Arató, et al. 2010 Mucosal expression of claudins 2, 3 and 4 in proximal and distal part of duodenum in children with coeliac disease Virchows Arch 456 245 250 20143085 10.1007/s00428-009-0879-7
11. A Tripathi KM Lammers S Goldblum, et al. 2009 Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2 Proc Natl Acad Sci U S A 106 16799 16804 19805376 10.1073/pnas.0906773106 1:CAS:528:DC%2BD1MXht1Ogs73K
12. VM Wolters BZ Alizadeh ME Weijerman, et al. 2010 Intestinal barrier gene variants may not explain the increased levels of antigliadin antibodies, suggesting other mechanisms than altered permeability Hum Immunol 71 392 396 20096742 10.1016/j.humimm.2010.01.016 1:CAS:528:DC%2BC3cXjs1Wqtrc%3D
13. M Mäkelä O Vaarala R Hermann, et al. 2006 Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin J Autoimmun 27 54 61 16757149 10.1016/j.jaut.2006.04.003 (Pubitemid 44403947)
14. M Mojibian H Chakir DE Lefebvre JA Crookshank B Sonier E Keely FW Scott 2009 Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes Diabetes 58 1789 1796 19401421 10.2337/db08-1579 1:CAS:528:DC%2BD1MXpsV2mtLc%3D
15. FC Westall 2007 Abnormal hormonal control of gut hydrolytic enzymes causes autoimmune attack on the CNS by production of immune-mimic and adjuvant molecules: a comprehensive explanation for the induction of multiple sclerosis Med Hypotheses 68 364 369 16978797 10.1016/j.mehy.2006.06.051 1:CAS:528:DC%2BD28Xht12qt7bP (Pubitemid 44879799)
16. H Yokote S Miyake JL Croxford S Oki H Mizusawa T Yamamura 2008 NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora Am J Pathol 173 1714 1723 18974295 10.2353/ajpath.2008.080622 1:CAS:528:DC%2BD1MXkt1CrtA%3D%3D
17. CJ Edwards 2008 Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis J Rheumatol 35 1477 14797 18671318
18. MT Abreu 2010 Toll-like receptor signaling in the intestinal epithelium: how bacterial recognition shapes intestinal function Nat Rev Immunol 10 131 144 20098461 10.1038/nri2707 1:CAS:528:DC%2BC3cXpslGnug%3D%3D
19. A Fasano 2008 Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall Am J Pathol 173 1243 1252 18832585 10.2353/ajpath.2008.080192 1:CAS:528:DC%2BD1cXhtlWntbnP
20. KR Groschwitz SP Hogan 2009 Intestinal barrier function: molecular regulation and disease pathogenesis J Allergy Clin Immunol 124 3 20 19560575 10.1016/j.jaci.2009.05.038 1:CAS:528:DC%2BD1MXnsl2gu7k%3D
21. A Fasano 2011 Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer Physiol Rev 91 151 175 21248165 10.1152/physrev.00003.2008 1:CAS:528:DC%2BC3MXisVCht78%3D
22. Cereijido M (1992) Evolution of ideas on the tight junction. In Tight Junction. CRC Press, Inc., Boca Raton, p 1
23. A Fasano B Baudry DW Pumplin, et al. 1991 Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions Proc Natl Acad Sci U S A 88 5242 5246 2052603 10.1073/pnas.88.12.5242 1:CAS:528:DyaK3MXkvVOitb4%3D (Pubitemid 21914720)
24. W Wang S Uzzau SE Goldblum, et al. 2000 Human zonulin, a potential modulator of intestinal tight junctions J Cell Sci 113 4435 4440 11082037 1:CAS:528:DC%2BD3MXmsVKmtg%3D%3D (Pubitemid 32117904)
25. A Fasano T Not W Wang, et al. 2000 Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease Lancet 358 1518 1519 10.1016/S0140-6736(00)02169-3 (Pubitemid 30237361)
26. R El Asmar P Panigrahi P Bamford, et al. 2002 Host-dependent activation of the zonulin system is involved in the impairment of the gut barrier function following bacterial colonization Gastroenterology 123 1607 1615 12404235 10.1053/gast.2002.36578 (Pubitemid 35231660)
27. D Branski A Fasano R Troncone 2006 Latest developments in the pathogenesis and treatment of celiac disease J Pediatr 149 295 300 16939736 10.1016/j.jpeds.2006.06.003 (Pubitemid 44308438)
28. A Fasano 2009 Surprises from celiac disease Sci Am 301 54 61 19634568 10.1038/scientificamerican0809-54 1:CAS:528:DC%2BD1MXpvFymtLY%3D
29. KM Lammers R Lu J Brownley, et al. 2008 Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3 Gastroenterology 135 194 204 18485912 10.1053/j.gastro.2008.03.023 1:CAS:528:DC%2BD1cXps1WltLk%3D (Pubitemid 351899011)
30. KE Thomas A Fasano SN Vogel 2006 Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease J Immunol 176 2512 2521 16456012 1:CAS:528:DC%2BD28XpvV2qsw%3D%3D (Pubitemid 43201702)
31. JR Turner 2009 Intestinal mucosal barrier function in health and disease Nat Rev Immunol 9 799 809 19855405 10.1038/nri2653 1:CAS:528:DC%2BD1MXhtlSqsb3J
32. B Jabri LM Sollid 2009 Tissue-mediated control of immunopathology in coeliac disease Nat Rev Immunol 9 858 870 19935805 10.1038/nri2670 1:CAS:528:DC%2BD1MXhsVOhur3O
33. M Maki T Huupponen K Holm O Hallstrom 1995 Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus Gut 36 239 242 7883223 10.1136/gut.36.2.239 1:STN:280:DyaK2M7ovFWnsw%3D%3D
34. P Collin J Salmi O Hallstrom 1989 High frequency of coeliac disease in adult patients with type 1 diabetes Scand J Gastroenterol 24 81 88 2784589 10.3109/00365528909092243 1:STN:280:DyaL1M7os1KjsA%3D%3D
35. Fasano A (2001) Pathological and therapeutical implications of macromolecule passage through the tight junction. In Tight junctions. CRC Press, Inc., Boca Raton, pp 697-722
36. R Carratù M Secondulfo L de Magistris, et al. 1999 Altered intestinal permeability to mannitol in diabetes mellitus type I J Pediatr Gastroenterol Nutr 28 264 271 10067726 10.1097/00005176-199903000-00010 (Pubitemid 29293647)
37. JB Meddings J Jarand SJ Urbanski, et al. 1999 Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat Am J Physiol 276 G951 G957 10198339 1:CAS:528:DyaK1MXislCks70%3D
38. T Watts I Berti A Sapone T Gerarduzzi T Not R Zielke A Fasano 2005 Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats Proc Natl Acad Sci U S A 102 2916 2921 15710870 10.1073/pnas.0500178102 1:CAS:528:DC%2BD2MXitVSktr0%3D (Pubitemid 40299891)
39. A Sapone L de Magistris M Pietzak, et al. 2006 Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives Diabetes 55 1443 1449 16644703 10.2337/db05-1593 1:CAS:528:DC%2BD28XksFahtbs%3D (Pubitemid 44195385)
40. FW Scott HE Cloutier R Kleeman, et al. 1997 Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats. Dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells Diabetes 46 589 598 9075798 10.2337/diabetes.46.4.589 1:CAS:528:DyaK2sXitFKqs74%3D (Pubitemid 27143374)
41. J Visser J Rozing A Sapone K Lammers A Fasano 2009 Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms Ann N Y Acad Sci 1165 195 205 19538307 10.1111/j.1749-6632.2009.04037. x 1:CAS:528:DC%2BD1MXot1Ghu7s%3D
42. JT Visser K Lammers A Hoogendijk, et al. 2010 Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat Diabetologia 53 2621 2628 20853098 10.1007/s00125-010-1903-9 1:CAS:528:DC%2BC3cXhtl2isLbK
43. M Simpson M Mojibian K Barriga F Scott A Fasano M Rewers J Norris 2009 An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus Pediatr Diabetes 10 563 572 19622083 10.1111/j.1399-5448.2009. 00541.x 1:CAS:528:DC%2BC3cXlslGqsg%3D%3D
44. Z Hijazi AM Molla H Al-Habashi, et al. 2004 Intestinal permeability is increased in bronchial asthma Arch Dis Child 89 227 229 14977697 10.1136/adc.2003.027680 1:STN:280:DC%2BD2c%2FovVWhug%3D%3D (Pubitemid 38325812)
45. B Yacyshyn J Meddings D Sadowski MB Bowen-Yacyshyn 1996 Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability Dig Dis Sci 41 2493 2501 9011463 10.1007/BF02100148 1:STN:280:DyaK2s7kvVKlsg%3D%3D (Pubitemid 27041808)
46. BR Yacyshyn JB Meddings 1995 CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability Gastroenterology 108 132 138 7528696 10.1016/0016-5085(95)90017-9 1:STN:280:DyaK2M7gsVKhtQ%3D%3D
47. H Schmitz C Barmeyer M Fromm, et al. 1999 Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis Gastroenterology 116 301 307 9922310 10.1016/S0016-5085(99)70126-5 1:STN:280:DyaK1M7it12msQ%3D%3D (Pubitemid 29055352)
48. CR Weber JR Turner 2007 Inflammatory bowel disease: is it really just another break in the wall? Gut 56 6 8 17172583 10.1136/gut.2006.104182 1:CAS:528:DC%2BD2sXhtF2qs7Y%3D (Pubitemid 46044880)
49. F Wang BT Schwarz WV Graham, et al. 2006 IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction Gastroenterology 131 1153 1163 17030185 10.1053/j.gastro.2006.08.022 1:CAS:528:DC%2BD28XhtFyqsr7M (Pubitemid 44515106)
50. 51Cr-EDTA Rev Esp Reumatol 19 253 256
51. O Martinez-Gonzalez J Cantero-Hinojosa P Paule-Sastre JC Gomez-Magan D Salvtierra-Rios 1994 Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives Br J Rheumatol 33 644 648 8019793 10.1093/rheumatology/33.7.644 1:STN:280:DyaK2c3ptVygtw%3D%3D
52. JH Vaile JB Meddings BR Yacyshyn AS Russell WP Maksymowych 1999 Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives J Rheumatol 26 128 133 9918253 1:STN:280:DyaK1M7hsVOrtw%3D%3D
53. J Liu P Zhu J Peng K Li J Du J Gu Y Ou 2007 Identification of disease-associated proteins by proteomic approach in ankylosing spondylitis Biochem Biophys Res Commun 357 531 536 17434140 10.1016/j.bbrc.2007.03.179 1:CAS:528:DC%2BD2sXksFehsrw%3D (Pubitemid 46603163)
54. BM Paterson KM Lammers MC Arrieta A Fasano JB Meddings 2007 The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in celiac disease subjects: a proof of concept study Aliment Pharmacol Ther 26 757 766 17697209 10.1111/j.1365-2036.2007.03413.x 1:CAS:528: DC%2BD2sXhtV2mtbbF (Pubitemid 47246202)
55. CP Kelly PH Green JA Murray, et al. 2009 Safety, tolerability and effects on intestinal permeability of larazotide acetate in celiac disease: results of a phase IIB 6-week gluten-challenge clinical trial Gastroenterology 136 Supplement 1 A-474 10.1016/S0016-5085(09)62182-X